Perianal Apse ve Fournier Gangreni
Özet
Perianal apse ve Fournier Gangreni (FG), anorektal ve perineal bölgeleri etkileyen ciddi enfeksiyonlardır. Anal kript bezlerinin tıkanmasıyla başlayan perianal apseler, erkeklerde iki kat daha yaygındır ve Crohn, diyabet ile sigara kullanımı önemli risk faktörleridir. Tanı konulduktan sonra sistemik enfeksiyon riski nedeniyle acil cerrahi drenaj gereklidir. Görüntülemede ilk aşamada doğruluk oranı yüksek olan MRG önerilmektedir. Tedavide cerrahi drenajın ardından ampirik antibiyotik kullanımı fistül oluşumunu azaltır. Fournier Gangreni ise yaşamı tehdit eden nekrotizan bir fasiittir ve polimikrobiyal kaynaklıdır. Genellikle diyabet ve obezite gibi immünosüpresif durumu olan bireylerde görülür. FG tanısı klinik olarak konur ve bilgisayarlı tomografi en yüksek spesifiteye sahip görüntüleme yöntemidir. FG'nin temel tedavisi, acil resüsitasyon ve geniş spektrumlu antibiyotik uygulamasının yanı sıra ilk 12 saat içinde yapılması gereken agresif ve kapsamlı cerrahi debridmandır. Postoperatif süreçte VAC pansuman yara bakımını kolaylaştırırken, seçili vakalarda fekal diversiyon için kolostomi gerekebilir.
Perianal abscess and Fournier's Gangrene (FG) are severe, life-threatening infections affecting the anorectal and perineal regions. Perianal abscesses, originating from obstructed anal crypt glands, are twice as common in men, with smoking, diabetes, and Crohn's disease serving as major risk factors. Immediate surgical drainage is vital to prevent systemic progression. MRI is recommended as the initial imaging modality due to its high diagnostic accuracy. Post-drainage empirical antibiotic therapy significantly reduces subsequent fistula formation. Fournier's Gangrene represents a life-threatening necrotizing fasciitis, primarily characterized by polymicrobial infections. It frequently compromises individuals with underlying immunosuppressive conditions such as diabetes and obesity. Diagnosis is predominantly clinical, where computed tomography provides the highest specificity. Management of FG demands urgent fluid resuscitation, broad-spectrum intravenous antibiotics, and early, aggressive surgical debridement executed within the first 12 hours of presentation. Postoperatively, negative pressure wound therapy (VAC) optimizes wound healing, while fecal diversion via colostomy may be considered in cases involving rectal and sphincter involvement.
Referanslar
Abcarian H. Anorectal infection: abscess-fistula. Clinical Colon Rectal Surgery. 2011;24(1):14-21.
Vogel JD, Johnson EK, Morris AM, Paquette IM, Saclarides TJ, Feingold DL, et al. Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. Disease of Colon and Rectum. 2016;59(12):1117-33.
Piazza DJ, Radhakrishnan J. Perianal abscess and fistula-in-ano in children. Disease of Colon and Rectum. 1990;33(12):1014-6.
Sainio P. Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Annales Chirurgiae Gynaecologiae. 1984;73(4):219-24.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Disease a Month. 2018;64(2):20-57.
Rizzo JA, Naig AL, Johnson EK. Anorectal abscess and fistula-in-ano: evidence-based management. Surgical Clinics of North America. 2010;90(1):45-68, Table of Contents.
Hermann G DL. Sur la muquese de la region cloacale de rectum. (III) Comptes Rendus Acad Sci.
Tucker C C HCA. Histopathology of anal glands. Surgery Gynecology Obstetrics .
Choen S, Burnett S, Bartram CI, Nicholls RJ. Comparison between anal endosonography and digital examination in the evaluation of anal fistulae. British Journal of Surgery. 1991;78(4):445-7.
Chapple KS, Spencer JA, Windsor AC, Wilson D, Ward J, Ambrose NS. Prognostic value of magnetic resonance imaging in the management of fistula-in-ano. Disease of Colon and Rectum. 2000;43(4):511-6.
Scholefield JH, Berry DP, Armitage NC, Wastie ML. Magnetic resonance imaging in the management of fistula in ano. International Journal Of Colorectal Disease. 1997;12(5):276-9.
Buchanan GN, Halligan S, Williams AB, Cohen CR, Tarroni D, Phillips RK, et al. Magnetic resonance imaging for primary fistula in ano. British Journal Of Surgery. 2003;90(7):877-81.
Beckingham IJ, Spencer JA, Ward J, Dyke GW, Adams C, Ambrose NS. Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging in the evaluation of fistula in ano. British Journal Of Surgery. 1996;83(10):1396-8.
O'Malley GF, Dominici P, Giraldo P, Aguilera E, Verma M, Lares C, et al. Routine packing of simple cutaneous abscesses is painful and probably unnecessary. Academic Emergency Medicine. 2009;16(5):470-3.
Tonkin DM, Murphy E, Brooke-Smith M, Hollington P, Rieger N, Hockley S, et al. Perianal abscess: a pilot study comparing packing with nonpacking of the abscess cavity. Disease of Colon and Rectum. 2004;47(9):1510-4.
Perera AP, Howell AM, Sodergren MH, Farne H, Darzi A, Purkayastha S, et al. A pilot randomised controlled trial evaluating postoperative packing of the perianal abscess. Langenbecks Archives Surgery. 2015;400(2):267-71.
Schouten WR, van Vroonhoven TJ. Treatment of anorectal abscess with or without primary fistulectomy. Results of a prospective randomized trial. Disease of Colon and Rectum. 1991;34(1):60-3.
Oliver I, Lacueva FJ, Perez Vicente F, Arroyo A, Ferrer R, Cansado P, et al. Randomized clinical trial comparing simple drainage of anorectal abscess with and without fistula track treatment. International Journal of Colorectal Disease. 2003;18(2):107-10.
Sawyer RG CJ, Nathens AB, et al. . Trial of short-course antimicrobial therapy for intraabdominal infection. . New England Journal of Medicine 2015; 372:1996n. 1996.
Mocanu V, Dang JT, Ladak F, Tian C, Wang H, Birch DW, et al. Antibiotic use in prevention of anal fistulas following incision and drainage of anorectal abscesses: A systematic review and meta-analysis. American Journal of Surgery. 2019;217(5):910-7.
Onaca N, Hirshberg A, Adar R. Early reoperation for perirectal abscess: a preventable complication. Disease of Colon and Rectum. 2001;44(10):1469-73.
B. W. Necrotizing fasciitis. American Journal Of Surgery. 1952;18:416–31. 1952.
Spirnak JP, Resnick MI, Hampel N, Persky L. Fournier's gangrene: report of 20 patients. Journal of Urology. 1984;131(2):289-91.
Roghmann F, von Bodman C, Loppenberg B, Hinkel A, Palisaar J, Noldus J. Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene. BJU International. 2012;110(9):1359-65.
Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes.Current Problems in Surgery. 2014;51(8):344-62.
J. J. Jones J. Surgical Memoirs of the War of the Rebellion. Investigation Upon the Nature, Causes, and Treatment of Hospital Gangrene as Prevailed in the Confederate Armies 1861-1865. United States Sanitary Commission; New York, NY: p. 1871. 1861.
Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. Journal of American College Of Surgeon. 2009;208(2):279-88.
Aldiwani M PV, Biyani C, Majumder S. Fournier’s gangrene: A review of contemporary management priorities. Global Surgery 2018;4:1-5. 2018.
Sorensen MD, Krieger JN. Fournier's Gangrene: Epidemiology and Outcomes in the General US Population. Urologia Internationalis. 2016;97(3):249-59.
Czymek R, Hildebrand P, Kleemann M, Roblick U, Hoffmann M, Jungbluth T, et al. New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients. Infection. 2009;37(4):306-12.
Ulug M, Gedik, E., Girgin, S., Celen, M. K. & Ayaz, C. . The evaluation of microbiology and Fournier’s gangrene severity index in 27 patients. . International Journal of Infectious Disease 13, e424–e430 (2009)
Clayton MD, Fowler, J. E. Jr, Sharifi, R. & , Pearl RK. Causes, presentation and survival of fiftyseven patients with necrotizing fasciitis of the male genitalia. . Surgery Gynecology Obstetrics 170, 49–55 (1990).
Kuo CF, Wang, W. S., Lee, C. M., Liu, C. P. & , Tseng HK. Fournier’s gangrene: ten-year experience in a medical center in northern Taiwan. . Journal Of Microbiology, Immunology, Infection 40, 500–506 (2007).
Hejase MJ, Simonin, J. E., Bihrle, R. & Coogan, C. L. . Genital Fournier’s gangrene: experience with 38 patients. . Urology 47, 734–739 1996.
Eke N. Fournier’s gangrene: a review of 1726 cases. . British Journal of Surgery 87, 718–728 (2000). 2000.
Unalp HRea. Fournier’s gangrene: evaluation of 68 patients and analysis of prognostic variables. . Journal Of Postgraduate Medicine 54, 102–105 2008.
Laor E, Palmer, L. S., Tolia, B. M., Reid, R. E. & , Winter HI. Outcome prediction in patients with Fournier’s gangrene. Journal of Urology 154, 89–92 1995.
Yeniyol CO, Suelozgen, T., Arslan, M. & Ayder, A. R. . Fournier’s gangrene: experience with 25 patients and use of Fournier’s gangrene severity index score. . Urology 64, 218–222 2004.
Corcoran AT, Smaldone, M. C., Gibbons, E. P., , Walsh TJD, B. J. Validation of the Fournier’s gangrene severity index in a large contemporary series. . Journal of Urology 180, 944–948. 2008.
Tuncel Aea. Fournier’s gangrene: three years of experience with 20 patients and validity of the Fournier’s gangrene severity index score. . European Urology 50, 838–843 2006.
Lujan Marco S, Budia, A., Di Capua, C., Broseta, E. , & Jimenez Cruz F. Evaluation of a severity score to predict the prognosis of Fournier’s gangrene. BJU International 106, 373–376 2010.
Yilmazlar Tea. Fournier’s gangrene: an analysis of 80 patients and a novel scoring system. . Techniques in Coloproctology 14, 217–223 2010.
Thwaini A KA, Malik A, et al. . Fournier’s gangrene and its emergency management. . Postgrad Med J 2006;82(970):516‐519 2005.
Voelzke BB HJ. Presentation and Diagnosis of Fournier Gangrene.Urology 2018;114:8‐13. 2018.
Yucel M, Ozpek A, Basak F, Kilic A, Unal E, Yuksekdag S, et al. Fournier's gangrene: A retrospective analysis of 25 patients. Ulusal Travma Acil Cerrahi Dergisi. 2017;23(5):400-4.
Bruketa T, Majerovic M, Augustin G. Rectal cancer and Fournier's gangrene - current knowledge and therapeutic options. World Journal of Gastroenterology. 2015;21(30):9002-20.
Kuzaka B, Wroblewska MM, Borkowski T, Kawecki D, Kuzaka P, Mlynarczyk G, et al. Fournier's Gangrene: Clinical Presentation of 13 Cases. Medical Science Monitor. 2018;24:548-55.
Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR American Journal of Roentgenology. 1998;170(3):615-20.
Ramakrishnan K, Salinas RC, Agudelo Higuita NI. Skin and Soft Tissue Infections. American academy of Family Physicians. 2015;92(6):474-83.
Levenson RB, Singh, A. K. & Novelline, R. A. . Fournier gangrene: role of imaging. . Radiographics 28, 519–528. 2008.
Norton KSea. Management of Fournier’s gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. . American Journal of Surgery 68, 709–713 (2002). 2002.
Bjurlin MAea. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier’s gangrene. . Urology 81, 752–758 2013.
Smaldone M, Corcoran, A. & Davies, B. . Fournier gangrene: advances in clinical management. . AUA update series 29, 170–179. 2010.
Frezza EEA, I. . Minimal debridement in the treatment of Fournier’s gangrene. . The American Journal of Surgery 65, 1031–1034 1999.
Eckmann C. The importance of source control in the management of severe skin and soft tissue infections. . Current Opinion in Infectious Disease 29, 139–144 2016.
Chao WNea. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. . The American Journal of Surgery 206, 32–39. 2013.
Stevens DLea. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.. Clinical Infectious Disease 59, 147–159 2014.
Haidari Mea. Honey in the treatment of Fournier’s gangrene as an adjuvant: a cross sectional study. . Jornal of Pakistan Medical Association 64, 571–573. 2014.
Mandal MDM, S. . Honey: its medicinal property and antibacterial activity. . Asian Pacific Journal of Tropical Biomedicine 1, 154–160. 2011.
Ye J, Xie, T., Wu, M., Ni, P. & Lu, S. Negative pressure wound therapy applied before and after split-thickness skin graft helps healing of Fournier gangrene: a case report (CARE-Compliant). . Medicine (Baltimore) 94, e426 2015.
Hagedorn JR, D. . in Advanced Male Urethral and Genital Reconstructive Surgery eds Brandes SBM, A. F., editor2014.
Assenza Mea. VAC (Vacuum Assisted Closure) treatment in Fournier’s gangrene: personal experience and literature review. Clinical Terapeutics 162, e1–e5. 2011.
Ozturk E, Ozguc, H. & Yilmazlar, T. . The use of vacuum assisted closure therapy in the management of Fournier’s gangrene. . The American Journal of Surgery 197, 660–665; discussion 665. 2009.
Milanese Gea. A conservative approach to perineal Fournier’s gangrene. . Archivio Italiano di Urologia e Andrologia 87, 28–32. 2015.
Akcan Aea. Necessity of preventive colostomy for Fournier’s gangrene of the anorectal region. . Ulusal Travma Acil Cerrahi Dergisi 15, 342–346 2009.
Eray ICea. Comparison of diverting colostomy and bowel management catheter applications in Fournier gangrene cases requiring fecal diversion. . Indian Journal of Surgery 77, 438–441. 2015.
